GR1007741B - Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents
Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτουInfo
- Publication number
- GR1007741B GR1007741B GR20110100406A GR20110100406A GR1007741B GR 1007741 B GR1007741 B GR 1007741B GR 20110100406 A GR20110100406 A GR 20110100406A GR 20110100406 A GR20110100406 A GR 20110100406A GR 1007741 B GR1007741 B GR 1007741B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- atypical antipsychotic
- antipsychotic agent
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σε μια σταθερή φαρμακευτική σύνθεση στερεάς μορφής για από του στόματος χορήγηση που να περιέχει μια θεραπευτικά αποτελεσματική ποσότητα ενός ατυπικού αντιψυχωτικού παράγοντα ή ενός φαρμακευτικά αποδεκτού άλατος, παραγώγου ή πολύμορφου αυτού, και συγκεκριμένα ολανζαπίνη σε συνδυασμό με ένα υδατοδιαλυτό αραιωτικό μέσο, ένα μόριο συνδέτη και ένα αποσαθρωτικό προκειμένου να εμποδιστούν η αποικοδόμηση ή και ανακρυστάλλωση. Αφορά επίσης μια μέθοδο για την παρασκευή αυτής.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100406A GR1007741B (el) | 2011-07-12 | 2011-07-12 | Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100406A GR1007741B (el) | 2011-07-12 | 2011-07-12 | Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1007741B true GR1007741B (el) | 2012-10-29 |
Family
ID=47321022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20110100406A GR1007741B (el) | 2011-07-12 | 2011-07-12 | Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1007741B (el) |
-
2011
- 2011-07-12 GR GR20110100406A patent/GR1007741B/el not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
IN2014KN00948A (el) | ||
PH12015500460B1 (en) | Coated pharmaceutical composition containing regorafenib | |
MX2015010858A (es) | Formas solidas de un inhbidor de cdk4/6 selectivo. | |
MY180666A (en) | Substituted pyrazolo [3,4-b] pyridines as medicaments | |
HK1149258A1 (en) | Compounds | |
MX2013012588A (es) | Inhibidores de cinasa. | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
WO2013188273A8 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
EP2823819A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING OLEANOLIC ACID ACETATE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MEDIATED DISEASE BY TLR OR IL-6 | |
MX359288B (es) | Forma iv del clorhidrato de ivabradina. | |
EP2796450A4 (en) | 6-AMINOPYRIDINE-3-OL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES OR THESE SALTS AS ACTIVE INGREDIENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS DISEASES | |
WO2013188268A8 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
TN2013000533A1 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
EP2722042A4 (en) | INDANONE DERIVATIVES, THEIR OPTICAL ISOMERS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | |
ZA201500362B (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
TN2015000280A1 (en) | Topical Ophthalmological Pharmaceutical Composition containing Regorafenib | |
WO2010137040A3 (en) | Novel pharmaceutical compositions of ranolazine | |
MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
WO2013188279A8 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
HK1223011A1 (zh) | 大葉冬青提取物為有效成分的藥物組合物 | |
GR1008821B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου | |
WO2012019428A8 (zh) | 二苯甲醇类衍生物、其制备方法及其在医药上的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20121122 |
|
ML | Lapse due to non-payment of fees |
Effective date: 20160202 |